InflaRx Appoints Global Head of Clinical Development
InflaRx N.V. has appointed Gabriela Alperovich, MD, PhD, as SVP & Global Head of Clinical Development. This role is effective October 1, 2026, and she will oversee programs including izicopan in AAV and other renal indications.